Organization · Venture Capital
Recode Ventures
Recode Ventures is a venture capital firm based in San Francisco and London, specializing in early-stage investments in healthcare AI companies. Founded in 2022, it focuses on supporting tech-native founders leveraging deep technology to address significant health challenges.
Overview
What Recode Ventures does
What Recode Ventures is
Recode Ventures is a venture capital firm based in San Francisco and London, specializing in early-stage investments in healthcare AI companies. Founded in 2022, it focuses on supporting tech-native founders leveraging deep technology to address significant health challenges.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Recode Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Recode Ventures as a funder
Investment thesis
Recode Ventures believes that the convergence of healthcare and deep technology creates strong opportunities for new healthcare platforms. They focus on investing in early-stage companies that leverage technology to address significant global health challenges.
Focus narrative
Recode Ventures invests in companies that operate at the intersection of healthcare and technology. Their investment thesis emphasizes the convergence of deep tech and healthcare, targeting sectors such as machine learning, nanotechnology, robotics, and augmented reality. The firm is particularly interested in addressing significant global health challenges, including cancer, neuroscience, heart disease, women's health, mental health, chronic diseases, and surgery.
Value beyond capital
Recode Ventures provides extensive support across research, drug development, product development, commercialization, market access, regulation, policy, and technology. Their team includes experienced professionals with backgrounds in medicine, engineering, and venture capital, enabling them to offer valuable insights and guidance to portfolio companies.
Focus and fit
- Stages
- Seed · Series A
- Sectors
- Healthcare · AI · Biotech · Digital Health · Medical Devices
- Regions
- North AmericaEurope
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 7
Portfolio context
Caption Care: Focuses on heart disease detection and management through convenient echocardiograms. Probably Genetic: Aims to expedite the diagnosis process for patients with rare conditions using a proprietary platform. Lab Genius: Combines human and machine intelligence to accelerate the discovery of advanced medicines. Waypoint Bio: Utilizes spatial biology and AI/ML to design better cell therapies for cancer. Proprio: Enhances surgical planning and execution through advanced AR/VR technologies. Nanograb: Employs computational biology and AI to target genetic drugs to specific tissues. Sensible Biotechnologies: Develops mRNA for therapeutic applications using novel design approaches.
Common questions
What to know about Recode Ventures
Upseed classifies Recode Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.